AxoGen (AXGN) Tops Q2 EPS by 6c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AXGN Hot Sheet
Join SI Premium – FREE
AxoGen (NASDAQ: AXGN) reported Q2 EPS of $0.12, $0.06 better than the analyst estimate of $0.06. Revenue for the quarter came in at $56.66 million versus the consensus estimate of $52.66 million.
GUIDANCE:
AxoGen sees FY2025 revenue of $219 million, versus the consensus of $216.18 million.
For earnings history and earnings-related data on AxoGen (AXGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Power Integrations (POWI) Tops Q3 EPS by 5c; Offers Guidance
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
